Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/9677460

Download in:

View as

General Info

PMID
9677460